계산
순이익률(Net Profit Margin Ratio) | = | 100 | × | 순이익(손실)1 | ÷ | 물품 판매1 | |
---|---|---|---|---|---|---|---|
2023. 12. 31. | -70.66% | = | 100 | × | (4,714) | ÷ | 6,671) |
2022. 12. 31. | 45.36% | = | 100 | × | 8,362) | ÷ | 18,435) |
2021. 12. 31. | 69.04% | = | 100 | × | 12,202) | ÷ | 17,675) |
2020. 12. 31. | -373.77% | = | 100 | × | (747) | ÷ | 200) |
2019. 12. 31. | — | = | 100 | × | (514) | ÷ | —) |
2018. 12. 31. | — | = | 100 | × | (385) | ÷ | —) |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31).
1 US$ 단위: 백만 달러
경쟁사와의 비교
Moderna Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023. 12. 31. | -70.66% | 8.95% | 24.96% | 17.83% | 19.94% | 15.36% | 21.03% | 41.28% | 0.61% | 3.56% | 30.14% | 13.99% | 36.68% |
2022. 12. 31. | 45.36% | 20.39% | 26.42% | 13.71% | 22.91% | 21.88% | 17.02% | 18.90% | 24.49% | 31.01% | 35.64% | 15.47% | 37.20% |
2021. 12. 31. | 69.04% | 20.54% | 24.25% | 15.08% | 21.84% | 19.71% | 23.05% | 22.26% | 26.79% | 26.76% | 50.25% | 19.70% | 30.92% |
2020. 12. 31. | -373.77% | 10.08% | 29.97% | -21.20% | 16.36% | 25.24% | 0.51% | 17.82% | 14.72% | 22.53% | 41.35% | 19.79% | 43.70% |
2019. 12. 31. | — | 23.69% | 35.32% | 13.15% | 16.80% | 37.27% | 24.35% | 18.42% | 21.01% | 31.45% | 26.91% | 14.47% | 28.27% |
2018. 12. 31. | — | 17.36% | 37.25% | 21.81% | 13.33% | 13.16% | 25.16% | 18.75% | 14.71% | 20.79% | 36.42% | 12.06% | 68.80% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Moderna Inc. | 제약, 생명공학 및 생명과학 | |
---|---|---|
2023. 12. 31. | -70.66% | 17.95% |
2022. 12. 31. | 45.36% | 22.55% |
2021. 12. 31. | 69.04% | 23.38% |
2020. 12. 31. | -373.77% | 14.07% |
2019. 12. 31. | — | 23.22% |
2018. 12. 31. | — | 19.82% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31).
업계와의 비교: 의료
Moderna Inc. | 의료 | |
---|---|---|
2023. 12. 31. | -70.66% | 9.24% |
2022. 12. 31. | 45.36% | 11.62% |
2021. 12. 31. | 69.04% | 12.42% |
2020. 12. 31. | -373.77% | 8.45% |
2019. 12. 31. | — | 11.58% |
2018. 12. 31. | — | 9.92% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31).